Gilead Sciences (Mexico) Buy Hold or Sell Recommendation
| GILD Stock | MXN 1,870 0.00 0.00% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Gilead Sciences is 'Sell'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Gilead Sciences given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Gilead Sciences, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Gilead Sciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Gilead Stock please use our How to Invest in Gilead Sciences guide. In addition, we conduct extensive research on individual companies such as Gilead and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Gilead Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Gilead |
Execute Gilead Sciences Buy or Sell Advice
The Gilead recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Gilead Sciences. Macroaxis does not own or have any residual interests in Gilead Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Gilead Sciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Good | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Gilead Sciences Trading Alerts and Improvement Suggestions
| Gilead Sciences has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Over 84.0% of the company shares are owned by institutional investors |
Gilead Sciences Returns Distribution Density
The distribution of Gilead Sciences' historical returns is an attempt to chart the uncertainty of Gilead Sciences' future price movements. The chart of the probability distribution of Gilead Sciences daily returns describes the distribution of returns around its average expected value. We use Gilead Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Gilead Sciences returns is essential to provide solid investment advice for Gilead Sciences.
| Mean Return | 0.25 | Value At Risk | -2.08 | Potential Upside | 3.07 | Standard Deviation | 1.69 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Gilead Sciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Gilead Sciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Gilead Sciences or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Gilead Sciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Gilead stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.25 | |
β | Beta against Dow Jones | -0.32 | |
σ | Overall volatility | 1.44 | |
Ir | Information ratio | 0.13 |
Gilead Sciences Volatility Alert
Gilead Sciences shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Gilead Sciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Gilead Sciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Gilead Sciences Fundamentals Vs Peers
Comparing Gilead Sciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Gilead Sciences' direct or indirect competition across all of the common fundamentals between Gilead Sciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Gilead Sciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Gilead Sciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Gilead Sciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Gilead Sciences to competition |
| Fundamentals | Gilead Sciences | Peer Average |
| Return On Equity | 0.22 | -0.31 |
| Return On Asset | 0.1 | -0.14 |
| Profit Margin | 0.17 % | (1.27) % |
| Operating Margin | 0.40 % | (5.51) % |
| Current Valuation | 2.55 T | 16.62 B |
| Shares Outstanding | 1.25 B | 571.82 M |
| Shares Owned By Institutions | 84.16 % | 39.21 % |
| Price To Earning | 282.94 X | 28.72 X |
| Price To Book | 5.19 X | 9.51 X |
| Price To Sales | 79.06 X | 11.42 X |
| Revenue | 27.28 B | 9.43 B |
| Gross Profit | 21.62 B | 27.38 B |
| EBITDA | 6.75 B | 3.9 B |
| Net Income | 4.59 B | 570.98 M |
| Cash And Equivalents | 29.01 B | 2.7 B |
| Cash Per Share | 22.81 X | 5.01 X |
| Total Debt | 25.18 B | 5.32 B |
| Debt To Equity | 122.50 % | 48.70 % |
| Current Ratio | 3.62 X | 2.16 X |
| Book Value Per Share | 17.01 X | 1.93 K |
| Cash Flow From Operations | 9.07 B | 971.22 M |
| Earnings Per Share | 68.39 X | 3.12 X |
| Price To Earnings To Growth | 0.70 X | 4.89 X |
| Number Of Employees | 38 | 18.84 K |
| Beta | 0.41 | -0.15 |
| Market Capitalization | 2.01 T | 19.03 B |
| Total Asset | 63.17 B | 29.47 B |
| Z Score | 47.4 | 8.72 |
| Annual Yield | 0.03 % | |
| Net Asset | 63.17 B | |
| Last Dividend Paid | 2.92 |
Gilead Sciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Gilead . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1870.0 | |||
| Day Typical Price | 1870.0 |
About Gilead Sciences Buy or Sell Advice
When is the right time to buy or sell Gilead Sciences? Buying financial instruments such as Gilead Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Gilead Sciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Aggressive Funds Thematic Idea Now
Aggressive Funds
Funds or Etfs that attempt to achieve high capital gains by investing in companies with high growth potential and above average risk. The Aggressive Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aggressive Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Gilead Stock Analysis
When running Gilead Sciences' price analysis, check to measure Gilead Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gilead Sciences is operating at the current time. Most of Gilead Sciences' value examination focuses on studying past and present price action to predict the probability of Gilead Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gilead Sciences' price. Additionally, you may evaluate how the addition of Gilead Sciences to your portfolios can decrease your overall portfolio volatility.